Chartered Trade Mark Attorney, Alexandra Nott explores some of the reasons that trade mark protection remains crucial in today’s business environment.
READ MORE
In this insight, Biotechnology partner Kit Wilkins reviews the US Supreme Court’s decision to Consider “Skinny Labels” in Generic Drug Patent Dispute. The decision could result in significant implications of generic medicines in the US.
READ MORE
In this insight, Holly Rocliffe from Dehns Biotechnology group explores the recently handed down decision in Otsuka Pharmaceutical Co Ltd v Sun Pharma ANZ Pty Ltd [2025] FCAFC 161[1], in which the Full Court of the Federal Court of Australia (Full Court) has ruled that patent term extension (PTE) is only available for patents which claim an active pharmaceutical ingredient (API).
READ MORE
The first decision from the UPC on sufficiency — handed down in the Amgen v. Sanofi case — provides the first clear guidance on how the court will address whether a patent’s disclosure is sufficient.
READ MORE
In this insight, Dehns Partner Rob Jackson and Conor Wilman from our Technology, Software and Engineering group explore the UPC’s Court of Appeal recent issues of two important decisions about how it will assess inventive step in patent cases.
READ MORE
The UK Intellectual Property Office (UKIPO) is consulting on possible changes to the UK design framework with the aims of improving design validity, simplifying the regime, and protecting emerging forms of design.
READ MORE
The G1/23 ruling from the European Patent Office marked a pivotal shift in how marketed products are treated as prior art, redefining the principles of reproducibility and disclosure across Europe. Dehns has collaborated with international patent experts to provide a global perspective on the ruling.
READ MORE
This decision concerned an application for provisional measures, in particular an anti-anti-suit injunction (‘AASI’), by Avago Technologies International Sales Pte. Limited against the defendant Realtek Semiconductor Corporation
READ MORE
Are you ready to commercialise your invention? What do you know about other people’s patents? Do you have Freedom to Operate?
Having your own patent does not mean that you can ignore other people’s patents. Before you start commercialising your invention, it is prudent to do a Freedom to Operate (FTO) search to try to find any patents that are relevant to your product or process.
This webinar outlines the reasons for undertaking an FTO search and the 3 stages of the FTO search and analysis.
In this episode we look at what happens if someone accuses you of infringing their patent:
All these questions, and more, answered by Dehns Patent Attorney, Dr Mark Bell.
Hosted on 13 August 2020 by Chris Goddard, qualified European and UK patent attorney and a Partner at Dehns, this webinar is the second in a two part series on Supplementary Protection Certificates (SPCs).
SPCs provide a valuable extension to patent protection in Europe for pharmaceutical, veterinary and plant protection products.
Perhaps not the ideal way to see in the new year, but rumour has it that one employee of Bass Brewery spent the cold New Year’s Eve of 1875 queuing outside the then Patent Office.
If you don’t have Freedom to Operate, the consequences for your business could be significant. This podcast looks at: what freedom to operate is; when you should think about it; how to check whether you have freedom to operate and what could happen if you don’t have freedom to operate; how a patent attorney can help.
This episode of The IP Podcast provides a quick introduction to the world of trade marks:
This webinar, jointly hosted on 23 July 2020, covers the patentability of diagnostic inventions in Europe, Canada and the US.
Today, the United Kingdom has formally withdrawn from the Unified Patent Court (UPC) system. Owing to the UK’s withdrawal from the system (as a consequence of Brexit) and a successful constitutional challenge in Germany to Germany’s proposed ratification of the UPC agreement, the UPC has yet to come into being
In this podcast we discuss how the Patent Box works, who is eligible to join the scheme, how to become eligible, how and when to join, and how to claim the reduced rate of tax.
In this episode, we look at the various ways in which you can get your patent granted overseas in the most cost effective way, including where, when and how you should make your patent applications.
Subscribe here for updates on IP news, events and webinars.
|